← Back to companies
Abalone Bio
2 open
Emeryville, California, United StatesFounded 201722+ employeesSeed raisedSeedPrivate
Last round: seed · $7.6M · May 2024(5 rounds total)
Founded by Gustavo Pesce, Richard Yu
Backed by(2 investors)
National Science FoundationY Combinator
The remarkable specificity and safety of antibody drugs have been limited to blocking inactivators for the largest class of drug targets. Abalone Bio develops antibody drugs that activate, enabling us to turn on previously inaccessible biological activities like anti-cancer or anti-inflammatory actions.
Open Positions at Abalone Bio (2 Jobs)
Ready to start your space career at Abalone Bio?
